Literature DB >> 36268198

Relationship of Bone Turnover Markers with Serum Uric Acid-to-Creatinine Ratio in Men and Postmenopausal Women with Type 2 Diabetes.

Yuling Xing1,2, Jing Liu1, Huanxin Liu3, Huijuan Ma1,4,5.   

Abstract

Purpose: Accumulating evidence has shown that serum uric acid (UA) is associated with some chronic diseases owing to its antioxidant capacity; however, previous research has discrepant results regarding the relationship between UA and bone health. UA normalized by renal function can reflect endogenous UA levels more precisely than SUA levels. This study assessed the relationship between serum UA-to-creatinine (SUA/Cr) ratio and bone turnover markers (BTMs) in men and postmenopausal women with type 2 diabetes mellitus (T2DM). Patients and
Methods: Overall, 1691 patients (1028 males and 663 postmenopausal females) with T2DM admitted to Hebei General Hospital between January and December 2020 were selected and divided into two groups according to their SUA/Cr ratio. One-way analysis of variance was used to compare groups. The relationship between the SUA/Cr ratio and BTMs (including osteocalcin [OC], procollagen I N-terminal peptide [PINP], and β-isomerized type I collagen C-telopeptide breakdown products [β-CTX]) was analyzed using multiple linear regression. Furthermore, subgroup analyses were performed to explore the differences between men and women in the relationship between SUA/Cr and BTMs. Mediation analysis was used to explore whether insulin resistance mediated the association between SUA/Cr and BTMs.
Results: β-CTX and PNIP levels of patients with T2DM in the low SUA/Cr group were significantly higher than those in the high SUA/Cr group, and the difference between the two groups was statistically significant (P < 0.05). Correlation analysis showed that SUA/Cr was negatively correlated with β-CTX and PNIP. After adjusting for confounding factors, multivariate linear regression analysis revealed that the SUA/Cr level was negatively correlated with PINP and β-CTX in male patients and postmenopausal women with T2DM. Stronger correlations were found in patients with 25(OH)D3 < 20ng/mL, course ≥ 5 years, HbA1c > 7%, or BMI < 28 kg/m2.
Conclusion: SUA/Cr ratio was an independent influencing factor of BTMs in patients with T2DM.
© 2022 Xing et al.

Entities:  

Keywords:  bone turnover markers; serum uric acid to creatinine ratio; type 2 diabetes

Year:  2022        PMID: 36268198      PMCID: PMC9578772          DOI: 10.2147/DMSO.S384694

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.249


  73 in total

1.  Update on type 2 diabetes-related osteoporosis.

Authors:  Kannikar Wongdee; Narattaphol Charoenphandhu
Journal:  World J Diabetes       Date:  2015-06-10

Review 2.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis.

Authors:  P Vestergaard
Journal:  Osteoporos Int       Date:  2006-10-27       Impact factor: 4.507

Review 3.  Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis.

Authors:  Fangke Hu; Chengying Jiang; Jing Shen; Peifu Tang; Yan Wang
Journal:  Injury       Date:  2011-06-17       Impact factor: 2.586

4.  Risk Factors for Nonalcoholic Fatty Liver Disease in Postmenopausal Women with Type 2 Diabetes Mellitus and the Correlation with Bone Mineral Density at Different Locations.

Authors:  Yi-Jun Du; Ni-Na Liu; Xing Zhong; Tian-Rong Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-21       Impact factor: 3.249

5.  Uric Acid Promotes Osteogenic Differentiation and Inhibits Adipogenic Differentiation of Human Bone Mesenchymal Stem Cells.

Authors:  Hui-Zhang Li; Zhi Chen; Cang-Long Hou; Yi-Xing Tang; Fei Wang; Qing-Ge Fu
Journal:  J Biochem Mol Toxicol       Date:  2015-04-28       Impact factor: 3.642

6.  C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.

Authors:  R Nesto
Journal:  Diabet Med       Date:  2004-08       Impact factor: 4.359

7.  Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.

Authors:  S Huang; M Kaw; M T Harris; N Ebraheim; M F McInerney; S M Najjar; B Lecka-Czernik
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

8.  Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.

Authors:  Yuri Y Sautin; Takahiko Nakagawa; Sergey Zharikov; Richard J Johnson
Journal:  Am J Physiol Cell Physiol       Date:  2007-04-11       Impact factor: 4.249

9.  The economic burden of fracture patients with osteoporosis in western China.

Authors:  B Qu; Y Ma; M Yan; H-H Wu; L Fan; D-F Liao; X-M Pan; Z Hong
Journal:  Osteoporos Int       Date:  2014-04-02       Impact factor: 4.507

Review 10.  Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties.

Authors:  Ann-Kristin Picke; Graeme Campbell; Nicola Napoli; Lorenz C Hofbauer; Martina Rauner
Journal:  Endocr Connect       Date:  2019-03-01       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.